Bio-Rad Laboratories gets $200 million amended and restated revolver

By Sara Rosenberg

New York, June 25 - Bio-Rad Laboratories Inc. closed on a $200 million amended and restated revolving credit facility due June 21, 2014, according to an 8-K filed with the Securities and Exchange Commission on Friday.

JPMorgan acted as the lead arranger, bookrunner and administrative agent on the deal that was completed on June 21.

There is a $100 million accordion feature.

Proceeds will be used to make permitted acquisitions, for working capital and for other general corporate purposes.

Bio-Rad is a Hercules, Calif.-based manufacturer and supplier of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.